Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%
 

TODAY'S TOPICS

1. ZACKS RANK BUY STOCKS: Today we highlight four new stocks: Martek Biosciences (MATK), Parker Hannifin (PH), JA Solar
(JASO) and Dryships (DRYS). Get these stories below.

2. BEST OF EQUITY RESEARCH: Five Dow companies - C, GE, IBM, INTC and JPM - are on the docket this week, along with well over 50 financial companies. Read the Earnings Preview and get our Bull and Bear Stocks of the Day.

3. STRATEGIES & IDEAS: Now is your chance to jump on the Top Ten Stocks for 2008. Don't miss this Investment Ideas article.

4. ZACKS EXTRA: The key to a buy-and-hold strategy is sticking with it until the company's fundamentals head south. Then its time to abandon ship. Learn more and get our free investing guidest.

Read current and past issues of this newsletter.

 

Your License to
Print Money

A few private investors have been guarding a secret for selecting market-beating stocks. They have consistently and extensively blown away the market producing average yearly gains of +44%, +47%, +65% and +89%. These investors rely on Zacks' "money machine" to find the best stocks. Don't hesitate to take advantage of this special opportunity to share in the windfall.

Click Here for Your FREE ZACKS INVESTMENT KIT.

Monday - January 14, 2008

1. ZACKS RANK BUY STOCKS

Zacks #1 Rank stocks average a 32% annual return. Every day on Zacks.com we highlight four new Zacks Rank Buy stocks based on the four main schools of investing: Aggressive Growth, Momentum, Growth & Income and Value.

 
Aggressive Growth - Martek Biosciences (MATK)

Martek Biosciences (MATK) increased penetration in international infant formula markets, expanded the use of DHA outside of infant formula and improved its gross margin and profitability. Read the full analysis on MATK now!

 
Growth & Income - Parker Hannifin Corporation (PH)

Parker Hannifin Corporation (PH) is scheduled to release second-quarter earnings results on Jan 17, 2008. Wall Street estimates for the year ending June of 2008 have increased over the past two months. Read the full analysis on PH now!

 
Momentum - JA Solar Holdings Co. (JASO)

JA Solar Holdings Co. (JASO) reported an awesome third quarter on Nov 9 in which revenue almost tripled from last year. Within the past seven days, analysts have increased estimates for this year and next. Read the full analysis on JASO now!

 
Value - Dryships (DRYS)

Dryships (DRYS) shares only trade for about 3.5x 2008 estimates of $18.02 per share. Analysts expect earnings to leap over 100% next year. Read the full analysis on DRYS now!

 

 
OTHER ZACKS RANK RESOURCES

  • Zacks Rank Home Page: Go there now.
     
  • All Zacks #1 Rank Stocks Learn more...
     
  • Zacks Momentum Trader: Get buy alerts for stocks that are ready to explode. Pinpoint the right stock at the right time with less volatility than the S&P 500. Learn more...
     
  • Our Zacks Champion Trader winner beat not only the competition, but beat the S&P 500 by 81.7%. Click here to trade like a champion.

2. BEST OF EQUITY RESEARCH

Back to top

The Zacks Equity Research team of 50 analysts generates a mountain of timely research every day that is geared towards long term stock investing. Here we turn the spotlight on some of their hottest insights.
 

EARNINGS PREVIEW for Jan 14 - Jan 18 with Charles Rotblut

Five Dow companies - C, GE, IBM, INTC and JPM - are on the docket this week, along with well over 50 financial companies. More...

 
ANALYST BLOG

Stocks featured recently include CRA International (CRAI), U.S. Cellular (USM), Benchmark Electronics (BHE) and Satyam Computer Services (SAY). To see the latest analyst posts,  click here.

 
BULL OF THE DAY

Regeneron (REGN) - Making Progress. For the full Zacks research report, click here.

 
BEAR OF THE DAY

Alcon, Inc. (ACL) - Expensive, with Setbacks. For the full Zacks research report, click here.

 
ZACKS ANALYST INTERVIEW

Parsing Bernanke's Speech

The situation isn't so bad that you should be investing in canned food and ammunition, as in hiding in a bunker. That said, CPB, KFT, LMT and NOC look good. More...

 
ZACKS INDUSTRY RANK with Charles Rotblut

Coal Rising

A recent rise in coal prices has created optimism for ACI, ICO, JRCC and MEE. More...

 
EARNINGS TRENDS with Dirk Van Dijk

Total Net Income Expected to Fall 8.5% for the S&P 500

The earnings declines are very concentrated in the Financial sector. FY08 estimates are also falling for many consumer stocks, with the exception of AZO, MCD and BBY. More...

 

 
OTHER ZACKS EQUITY RESEARCH RESOURCES

  • Zacks Equity Research Home Page: Go there now.
     
  • All Rating Upgrades Learn more...
     
  • Zacks Elite narrows down Zacks Equity Research recommendations into three focused portfolios. Learn more...
     
  • Zacks Top 10 Stocks for 2008: Buy 'em. Do nothing. Beat the market. (Up 33% in 2007). Learn more...
     

3. STRATEGIES & IDEAS

Back to top

Here you will find fresh articles loaded with profitable investment strategies and ideas to help you beat the market. Today we highlight...

 
INVESTMENT IDEAS

8x the S&P Return Isn't Bad

Now is your chance to jump on the Top Ten Stocks for 2008. Stocks highlighted include SII, SGP, FPL and PCLN. More...

 
PROFIT TRACKS: EARNINGS AND MARGINS

This strategy combines solid earnings with a healthy net profit margin. Four stocks that pass this screen's test include TGB, GII, NGS and GLF. More...

 
SCREEN OF THE WEEK

Sizing Up the Markets

Find out which Market Caps performed the best in 2007. You might be surprised. Stocks highlighted include FLS, RIMM and NOV. More...

 
ZACKS WEALTH MANAGEMENT

Accessing Your IRA Penalty Free

There are circumstances where you can avoid the 10% penalty when tapping into your traditional IRA More...

 
FREE REPORT: Top 10 Stock Picking Strategies

Most of the strategies highlighted in the articles above were created using the Zacks Research Wizard screening and backtesting software. Learn more about this powerful tool and get your free copy of our special report "Top 10 Stock Screening Strategies". More...


4. ZACKS EXTRA

Back to top

 
EDUCATION

Growth & Income Investing

Know When to Hold `Em and Know When to Fold `Em
The key to a buy-and-hold strategy is sticking with it until the company's fundamentals head south. Then its time to abandon ship. Read the complete commentary.

Growth & Income Investing Home: Go there now.

Other Investing Education Resources

 

 
MITCH ON THE MARKETS (AUDIO)

Mitch Zacks, Portfolio Manager at Zacks Investment Management, reacts to the recent Fed rate cut and other issues impacting the stock market and econom. Listen to his audio here.

Click here for more Zacks audio.

 

 
OPTIONS

Verasun Energy (VSE)

The company has room for upgrades, which makes it an attractive contrarian play to the experts at Schaeffer's. More...

Options homepage: Go there now.


 
3 Timely Buy Stocks

Top stock picks including a footwear manufacturer, a power company as well as an auctioneer have all been part of Zacks Timely Buys, which have outperformed the S&P 500 for 10 out the last 11 years. Rocket-bound stocks are immediately available to you.

Click here to take advantage of gains which are expected to last 30 to 90 days.
 


 

 
OTHER POPULAR FEATURES FROM ZACKS

 

 
Manage your Profit from the Pros subscription:

 
REFER-A-FRIEND

If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS! http://at.zacks.com/?id=2311

Regards and Happy Investing,

Charles Rotblut, CFA
Senior Market Analyst
Zacks.com

p.s. What is the mission for Zacks Profit from the Pros? Click here to find out how we will help you become a more successful investor.


The performance of the Zacks Rank portfolios shown above for annual and year-to-date periods are the linked monthly total returns (price changes + dividends) of equal weighted hypothetical portfolios, consisting of those stocks with the indicated Zacks Rank, assuming monthly rebalancing and zero transaction costs. These are not the returns of actual portfolios. The hypothetical portfolios were created at the beginning of each month from Jan 1988 forward based on the values of the Zacks Rank available to Zacks' clients before the beginning of each month. The portfolios created monthly from 1988 through September 2006 exclude ADRS and are comprised of stocks that have the indicated Zacks Rank and were covered by at least two analysts at the time of the stocks inclusion in the portfolio. Starting in October 2006 and going forward, the portfolios are comprised of all stocks with the indicated Zacks Rank and do not exclude ADRs, which is more reflective of the list of stocks that customers will find on the Zacks web sites. 2007 returns are for the period of Jan 1 - Jun 30, 2007. These performance numbers have been audited from 1995 through 2003 by Autschuler Melovan, a division of American Express Financial.

The S&P 500 Index is a well-known, unmanaged index of the prices of 500 large-company common stocks, mainly blue-chip stocks, selected by Standard & Poor's. The S&P 500 Index assumes reinvestment of dividends but does not reflect advisory fees. An investor cannot invest directly in an index.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

To contact us by mail:

Zacks Investment Research
Attn: Profit from the Pros
111 N. Canal St., Suite 1101
Chicago, IL 60606

To unsubscribe from receiving "Profit from the Pros" e-mail newsletter, click here.


 

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.